*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Sitagliptin EP Impurity A is a critical reference standard for the pharmaceutical analysis of Sitagliptin. It serves as a degradation product or synthetic by-product defined under European Pharmacopoeia guidelines. The compound features the <strong>molecular formula C16H20N4O</strong> and carries the <strong>CAS number 486459-67-6</strong>. Production involves precise organic synthesis to ensure high purity for quality control validation.</p>
<h3>Application</h3>
<ul>
<li><strong>Quality Control:</strong> Used in HPLC method development to identify and quantify trace impurities in active pharmaceutical ingredients.</li>
<li><strong>Regulatory Compliance:</strong> Essential for generating stability-indicating data required by FDA and EMA submissions.</li>
<li><strong>R&D Studies:</strong> Employed in toxicological profiling during drug discovery phases to assess safety margins.</li>
</ul>
<h3>Precautions</h3>
<ul>
<li><strong>Storage:</strong> Maintain at -20°C in a dry, inert atmosphere to prevent hydrolysis.</li>
<li><strong>Safety:</strong> Handle with appropriate PPE; avoid inhalation or skin contact due to potential allergenic properties.</li>
<li><strong>Usage:</strong> Strictly for laboratory research and analytical calibration; not intended for clinical administration.</li>
</ul>